I’ll introduce myself first, then jump into the reason why I’m writing to you today. This is an early- entry opportunity that I’ve been tracking over the last several months…one that could significantly outperform what occurred over the last decade in the medical cannabis sector.
There’s a massive gap in the mental health pharmaceutical field waiting to be filled…a hole in the United States alone that passed $238 billion market size in 2020.*
This field is wide open to innovation and some Silicon Valley billionaires who recognize the potential have backed a group of world renown medical researchers to fill the gaps.
I’m Charles Moskowitz, editor of The Moskowitz Report, a private advisory publication that focuses on alerting readers to emerging trends in the market that hold exceptional investment potential.
After nearly three decades studying market movement, I have found that recognizing an emerging trend exposes exceptional opportunities for finding young companies on the threshold of greatness.
If you would like to read my PRIVATE EARLY REPORT online just go here.
READ SPECIAL REPORT
I promise you, reading this report is more than worthwhile…it could be life changing.
In addition, I’ve enclosed an attractive “Welcome Aboard” offer for new subscribers to The Moskowitz Report. As you will see from the enclosed materials, my editorial focus points heavily to identifying emerging trends that can return enormous gains to those who learn of them early.
Here’s the thing. You likely know the old adage, “The trend is your friend.” Imagine the opportunities if you were alerted in advance of a trend first forming. I’m talking about the time when only industry insiders and visionaries had sense of what was taking place.
Many of the richest companies in the world today got their starts at the base of a trendline…rising to fabulous wealth for investors lucky enough to secure an early position.
They bought and held. They ignored the skeptics, and now they’re rich for their foresight and tenacity.
So yes, the trend is your friend…and it can be very friendly when you get in early.
That’s the focus of the quick mini-report that I have included with this mailing. It’s about an emerging trend in biotechnology. Here’s the essence of it.
Thanks to the recent revolution in medical marijuana research, pathways have been opened for drug discoveries that had been banned from research for the last five decades.
In the 60s and 70s, compounds that are now showing promise in pharmacology were profoundly abused in dark market channels. Legitimate researchers strictly avoided studying these.
Fast forward 50 years to the birth of the medical cannabis sector. In a few short years of progress toward legalization, cannabis is becoming the source for a remarkable new class of medications, cannabinoids. It launched a trend (ongoing still) that opened one of the biggest money-makers the market has seen in years. Though opportunity still exists in the sector, it’s appears insignificant to what is following…what I call Phase Two in a Mental Health Renaissance.
On the heels of new cannabis research comes pharmacological research into the medicinal potential of compounds deceptively classified as psychedelics. Psilocybin tops the list of psychedelics being evaluated for treatment of mental disorders or traumatic brain injury. What’s being discovered is that the active compound, psilocybin, interacts with the brain and nervous system in such a way that it potentially mitigates symptoms and may even promote healing.
Two years ago, when this first caught my attention. I categorized it as “in its infancy”. Now it is maturing…gaining traction…and it’s attracting serious money from Silicon Valley billionaires, the federal government and even the U.S. military. The next step is the public market…astute investors enter well in advance of that.
Right now I’m preparing a long report that gets into more detail and points to a market I believe could accelerate much faster than the cannabis sector…and it’s just getting started.
Please review the enclosed mini-report and let me know what you think. I also invite you to take advantage of a special introductory subscription offer to my Moskowitz Report. You’ll be seeing a lot more coverage of this and other emerging trends in the months ahead.
Remember, the trend is your friend…especially when you recognize it early! Yours for Investing Success,
Charles Moskowitz
READ SPECIAL REPORT
* https://www.statista.com/statistics/252393/total-us-expenditure-for-mental-health-services/
